3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000685062, WCTU-FOLFERA, EUDRACT-2009-012151-23, ISRCTN-73199181, CRUK-09/023, WCTU-SPON-671-09, EU-21071, ZENECA-WCTU-FOLFERA, NCT01205711
|